Scarborough Advisors »

Clearside Biomedical shares owned by Scarborough Advisors

Quarter-by-quarter ownership of Clearside Biomedical (CLSD) shares owned by Scarborough Advisors from 13F filings

Historical chart of Scarborough Advisors investment in Clearside Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Clearside Biomedical held by Scarborough Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Clearside Biomedical by Scarborough Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $324 277 1.17

More positions owned by Scarborough Advisors

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Ser Tr Russell Low Vol (ONEV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Msci Intl Qualty (IQLT)
Ishares Msci Emrg Chn (EMXC)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)

View all positions for Scarborough Advisors

Top funds holding Clearside Biomedical

Rosalind Advisors
Vanguard Group
Brown Wealth Management
Northeast Financial Consultants
Citadel Advisors
Captrust Financial Advisors
Banque Cantonale Vaudoise
International Assets Investment Management
Stifel Financial
Millennium Management
Curi Wealth Management
Charles Schwab Investment Management
Mariner Wealth Advisors
Virtu Financial
Stratos Wealth Advisors

View all funds holding Clearside Biomedical